Depression with the Use of Alpha-Methyldopa
Abstract
We have reported a case of depression associated with alpha-methyldopa treatment in which there was a history of prior mood disturbances associated with the use of other drugs which can also alter catecholamine levels. Since most antihypertensive agents depend on the altered metabolism of catecholamines for their action, any such drugs can be expected to produce undesired psychic effects, particularly mood disturbances.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
